SK280298B6 - Izochinolíny, spôsob ich prípravy, farmaceutické p - Google Patents

Izochinolíny, spôsob ich prípravy, farmaceutické p Download PDF

Info

Publication number
SK280298B6
SK280298B6 SK1319-94A SK131994A SK280298B6 SK 280298 B6 SK280298 B6 SK 280298B6 SK 131994 A SK131994 A SK 131994A SK 280298 B6 SK280298 B6 SK 280298B6
Authority
SK
Slovakia
Prior art keywords
formula
isoquinoline
ester
acid
treatment
Prior art date
Application number
SK1319-94A
Other languages
English (en)
Slovak (sk)
Other versions
SK131994A3 (en
Inventor
Reto Naef
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK131994A3 publication Critical patent/SK131994A3/sk
Publication of SK280298B6 publication Critical patent/SK280298B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1319-94A 1993-11-05 1994-11-03 Izochinolíny, spôsob ich prípravy, farmaceutické p SK280298B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939322828A GB9322828D0 (en) 1993-11-05 1993-11-05 Organic compounds

Publications (2)

Publication Number Publication Date
SK131994A3 SK131994A3 (en) 1995-06-07
SK280298B6 true SK280298B6 (sk) 1999-11-08

Family

ID=10744697

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1319-94A SK280298B6 (sk) 1993-11-05 1994-11-03 Izochinolíny, spôsob ich prípravy, farmaceutické p

Country Status (26)

Country Link
US (1) US5747506A (no)
EP (1) EP0664289A3 (no)
JP (1) JPH07188176A (no)
KR (1) KR950014073A (no)
CN (1) CN1051998C (no)
AT (1) AT404940B (no)
AU (1) AU685852B2 (no)
CA (1) CA2135000A1 (no)
CH (1) CH688478A5 (no)
CZ (1) CZ282329B6 (no)
DE (1) DE4438737A1 (no)
FI (1) FI945191A (no)
FR (1) FR2711989B1 (no)
GB (2) GB9322828D0 (no)
HK (1) HK1005776A1 (no)
HU (1) HU217120B (no)
IL (1) IL111518A (no)
IT (1) IT1273993B (no)
NO (1) NO302293B1 (no)
NZ (1) NZ264851A (no)
PE (1) PE30395A1 (no)
PL (1) PL178210B1 (no)
RU (1) RU2144027C1 (no)
SK (1) SK280298B6 (no)
TW (1) TW353067B (no)
ZA (1) ZA948738B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
ID19155A (id) * 1996-12-13 1998-06-18 Tanabe Seiyaku Co Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya
US5919794A (en) * 1998-05-11 1999-07-06 Virginia Commonwealth University Methods of using pharmaceutical tetrahydroisoquinolines
US6200771B1 (en) * 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
IL132407A0 (en) * 1998-10-21 2001-03-19 Pfizer Prod Inc Method for treating congestive heart failure
DE19930614A1 (de) * 1999-07-02 2001-01-04 Mann & Hummel Filter Filtereinsatz
PT1212089E (pt) 1999-08-21 2006-08-31 Altana Pharma Ag Combinacao sinergica de roflumilast e salmeterol
JP2003526677A (ja) * 2000-03-14 2003-09-09 ザ・ユニバーシテイ・オブ・ウエスタン・オンタリオ 骨形成に影響を与える組成物および方法
WO2002040449A1 (en) * 2000-11-14 2002-05-23 Altana Pharma Ag Dihydroisoquinolines as novel phosphodiesterase inhibitors
WO2002040450A1 (en) 2000-11-14 2002-05-23 Altana Pharma Ag (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors
DE10229762A1 (de) * 2002-07-03 2004-01-22 Aventis Pharma Deutschland Gmbh Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
MXPA05010373A (es) 2003-04-01 2005-12-05 Applied Research Systems Inhibidores de fosfodiesterasas en infertilidad.
US7795385B2 (en) * 2004-12-17 2010-09-14 Bexar Global, Inc. Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
ES2393885T7 (es) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
BRPI0919282A2 (pt) * 2008-10-02 2017-03-28 Asahi Kasei Pharma Corp composto, composição farmacêutica, inibidor de ikkb, método para inibir ikkb, métodos para prevenir e/ou tratar uma doença ou sintoma associado com nf-kb, uma doença ou sintoma associado com ikkb, e uma doença ou sintoma associado com reação inflamatória aguda ou crônica em mamíferos
JP6265583B2 (ja) 2008-10-17 2018-01-24 ウィスコンシン アルムニ リサーチ ファンデイション 生理活性アルファベータペプチドを作製する方法
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9580471B2 (en) 2011-03-01 2017-02-28 Synergy Pharmaceuticals, Inc. Process of preparing guanylate cyclase C agonists
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
KR20220147691A (ko) 2013-08-09 2022-11-03 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB645139A (en) * 1946-10-22 1950-10-25 Servita Gyogyszeryar Es Vegyip Improved process for the production of isoquinoline derivatives
GB1400425A (en) * 1971-09-22 1975-07-16 Rolland Sa A Substituted 3-hydroxymethyl-isoquinolines and derivatives
US3878215A (en) * 1971-12-01 1975-04-15 Sandoz Ag 2-Alkyl-3-substituted-4-aryl isoquinolines
US4018927A (en) * 1973-12-17 1977-04-19 The Regents Of The University Of Michigan Treatment of proliferating skin diseases with papaverine alkaloids
KR840002104B1 (ko) * 1980-08-08 1984-11-15 부자 앙드레 신규 이소퀴놀린 유도체의 제법
HU183479B (en) * 1981-06-16 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new 6,7-diethoxy-1-aracket-4-ethoxy-3-hydroxy-benzyl-bracket closed-3,4-dihydroisoquinolin
DE3244594A1 (de) * 1982-12-02 1984-06-07 Hoechst Ag, 6230 Frankfurt 1-phenylisochinolinderivate und verfahren zu ihrer herstellung, diese verbindung enthaltende pharmazeutische praeparate und deren anwendung
GB8328052D0 (en) * 1983-10-20 1983-11-23 Beecham Group Plc Compounds
US4761403A (en) * 1986-04-09 1988-08-02 Abbott Laboratories Lipoxygenase inhibiting compounds
CA1330560C (en) * 1986-05-21 1994-07-05 Maurits E. A. Vandewalle Di- and tetrahydroisoquinoline derivatives
HU196758B (en) * 1986-05-21 1989-01-30 Gyogyszerkutato Intezet Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them
GB8800397D0 (en) * 1988-01-08 1988-02-10 Sandoz Ltd Improvements in/relating to organic compounds
GB9027055D0 (en) * 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
ATA204894A (de) 1998-08-15
SK131994A3 (en) 1995-06-07
ITRM940706A1 (it) 1996-05-03
ITRM940706A0 (it) 1994-11-03
CA2135000A1 (en) 1995-05-06
GB9322828D0 (en) 1993-12-22
NZ264851A (en) 1996-04-26
GB2283488A (en) 1995-05-10
AU7761094A (en) 1995-05-18
FI945191A0 (fi) 1994-11-03
NO944187D0 (no) 1994-11-03
DE4438737A1 (de) 1995-05-11
AU685852B2 (en) 1998-01-29
HU217120B (hu) 1999-11-29
PL178210B1 (pl) 2000-03-31
RU2144027C1 (ru) 2000-01-10
FR2711989A1 (fr) 1995-05-12
CH688478A5 (de) 1997-10-15
CZ269894A3 (en) 1995-07-12
EP0664289A2 (en) 1995-07-26
CN1051998C (zh) 2000-05-03
IT1273993B (it) 1997-07-14
RU94040170A (ru) 1996-10-10
HK1005776A1 (en) 1999-01-22
FI945191A (fi) 1995-05-06
KR950014073A (ko) 1995-06-15
EP0664289A3 (en) 1995-09-13
GB2283488B (en) 1997-12-03
GB9421985D0 (en) 1994-12-21
IL111518A (en) 1999-06-20
AT404940B (de) 1999-03-25
FR2711989B1 (fr) 1996-06-14
PE30395A1 (es) 1995-10-25
CN1106801A (zh) 1995-08-16
IL111518A0 (en) 1995-01-24
CZ282329B6 (cs) 1997-06-11
PL305705A1 (en) 1995-05-15
US5747506A (en) 1998-05-05
NO944187L (no) 1995-05-08
NO302293B1 (no) 1998-02-16
TW353067B (en) 1999-02-21
HU9403184D0 (en) 1994-12-28
HUT71350A (en) 1995-11-28
JPH07188176A (ja) 1995-07-25
ZA948738B (en) 1996-05-06

Similar Documents

Publication Publication Date Title
SK280298B6 (sk) Izochinolíny, spôsob ich prípravy, farmaceutické p
CS375791A3 (en) Novel dihydroisoquinoline derivatives
SK283562B6 (sk) 8-Aryl-1,7-naftyridínové deriváty, farmaceutické prostriedky, ktoré ich obsahujú, ich použitie, spôsob ich prípravy a medziprodukty použité v tomto spôsobe
WO2005063732A1 (en) Compounds and methods for the treatment of asthma
US20040147544A1 (en) Pde4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases
JPH0649686B2 (ja) イソキノリン誘導体、その製法および用途
JPH0631236B2 (ja) 新規キサンチン誘導体
SK279277B6 (sk) Farmaceutický prostriedok proti aterosklerotickému
EP1030844A1 (en) Compounds which inhibit tryptase activity
SK63998A3 (en) Quinoline derivatives, method for the preparation thereof, pharmaceutical composition containing same, and their use
WO2007106706A1 (en) Cyclic urea compounds as soluble epoxide hydrolase inhibitors effective for the treatment of cardiovascular disorders
JP2021515811A (ja) 3”,5”−ジアルコシベンゾイル−3’−アミノ−3’−デオキシアデノシン−5’−三リン酸及びその医薬用途
US20040167153A1 (en) Pharmaceutical combination
MX2011007697A (es) Pirrolopirimidindiona dimerica y su uso en terapia de enfermedades respiratorias.
JP2000038382A (ja) 新規ベンゾフラノン誘導体及びその製造方法
AU2002344167A1 (en) A PDE 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases